Scout | Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed)

This grant opportunity seeks applications from new Recruitment Sites to enroll adults and/or children with Type 1 diabetes, who are at high risk of or have diabetic nephropathy, into a long-term study involving kidney biopsies. The chosen sites will work with the Kidney Precision Medicine Project to study these biopsies, help create a Kidney Tissue Atlas, categorize disease types, and find tar…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Diabetes and Digestive and Kidney Diseases

Award

Award Ceiling: $400,000

Funding Amount: $400,000

Dates

Opportunity Released: September 26, 2024

Open for Submission: September 26, 2024

Submission Deadline: December 10, 2024

Application Window Closes: December 10, 2024

Keywords

Type 1 diabetes

diabetic nephropathy

longitudinal cohort study

kidney biopsies

Kidney Precision Medicine Project

Kidney Tissue Atlas

disease subgroups

novel therapies

adult and pediatric patients

recruitment sites.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers